MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SB290157 trifluoroacetate

CAS No. : 1140525-25-2

MCE 站：SB290157 trifluoroacetate

产品活性：SB290157 trifluoroacetate是有效，选择性的C3a受体的拮抗剂，IC₅₀值为200 nM。

研究领域：Immunology/Inflammation

作用靶点：Complement System

In Vitro: SB 290157, functions as a competitive antagonist of ¹²⁵I-C3a radioligand binding to rat basophilic leukemia-2H3 cells expressing the human C3aR (RBL-C3aR), with an IC₅₀ of 200 nM. SB 290157 blocks C3a-induced C3aR internalization in a concentration-dependent manner and C3a-induced Ca²⁺ mobilization in RBL-C3aR cells and human neutrophils with IC₅₀s f 27.7 and 28 nM, respectively. SB 290157 is selective for the C3aR in that it does not antagonize the C5aR or six other chemotactic G protein-coupled receptors. SB 290157 also inhibits C3a-induced Ca²⁺ mobilization of RBL-2H3 cells expressing the mouse and guinea pig C3aRs. It potently inhibits C3a-mediated ATP release from guinea pig platelets and inhibits C3a-induced potentiation of the contractile response to field stimulation of perfused rat caudal artery.

In Vivo: SB 290157, inhibits neutrophil recruitment in a guinea pig LPS-induced airway neutrophilia model and decreases paw edema in a rat adjuvant-induced arthritis model. The antagonist is able to reduce joint swelling only at 3 h, and about 50% inhibition of joint swelling is observed with the concentration of 30 mg/kg. The C3 level is significantly decreased at 3 h compared with naive mice showing complement consumption. Furthermore, the C3 activation is observed and increased corresponding to the graded concentration of anti-OVA pAb.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Peptidomimetic Library  |  Anti-Blood Cancer Compound Library  |  Dexamethasone  |  Cyclosporin A  |  EG00229  |  PMX-53  |  PMX 205 Trifluoroacetate  |  Leukadherin-1  |  EG01377 dihydrochloride  |  BCX 1470 methanesulfonate  |  W-54011  |  Compstatin  |  TLQP-21 TFA  |  C3a (70-77) TFA  |  FD-IN-1  |  NDT 9513727  |  Compstatin control peptide  |  POT-4

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。